Dabogratinib
245 Inquiries
2800223-30-5
99%
SHA
mce
1g
2026-02-22
Building block
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceDabogratinib(TYRA-300) , a 3-pyridylindazole analog, is a reversible and selective inhibitor of FGFR3 with an IC50 of 11 nM in Ba/F3 cells. It also exhibit potent activity in human bladder cancer cell lines harboring FGFR3 activating fusions or mutations.Basic Info
-
Product Name:
TYRA-300
Other Name:TYRA-300;2,6-Diazaspiro[3.3]heptane, 2-[5-[5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]-2-pyridinyl]-6-(methylsulfonyl)-;(R)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(6-(6-(methylsulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-3-yl)-1H-indazole;TYRA-300(Dabogratinib);Tyra-300 99% Shaanxi Dideu Medichem
CAS No.:2800223-30-5
Molecular Formula:C25H24Cl2N6O3S
InChIKeys:JOAFWIHZEBKYQK-OAHLLOKOSA-N
Molecular Weight:559.47
EC Number:610-261-8
Categories:
Characteristics-
Density:
1.58±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
Boiling Point:791.2±70.0 °C(predicted)
PKA:11.87±0.40(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Building block
-
Location:
5th floor,No.137-138, Lane 456,Jieqiao Road
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Inquiry History245 Inquiries
Country Product Purchase Quantity Date Posted 
India
Tyra-300 CAS 2800223-30-5
9 G Jul 8, 2026 
United States
TYRA-300 CAS 2800223-30-5
8 G Jul 14, 2026 
Australia
Wholesale TYRA-300 Powder CAS 2800223-30-5 with Best Price
1 G Sep 21, 2026
United States
Wholesale TYRA-300 Powder CAS 2800223-30-5 with Best Price
5 G Sep 11, 2026
United States
High Quality TYRA-300 99% powder 2800223-30-5 Shaanxi Dideu Medichem Co.Ltd
8 G Aug 2, 2026 
Germany
TYRA-300
5 G Aug 1, 2026
United States
Dabogratinib
5 G Oct 24, 2026 
Portugal
TYRA 300
100 G Oct 22, 2026
Germany
TYRA-300
5 MG Oct 19, 2026
United States
Tyra-300
1 G Oct 18, 2026 
United Kingdom
Tyra 300
1 G Oct 17, 2026
United Kingdom
Tyra 300
1 MT Oct 16, 2026 
Taiwan, China
Tyra 300
3 G Oct 16, 2026 
Norway
Tyra 300
6 G Oct 15, 2026
United States
Tyra 300
1 G Oct 14, 2026 
Hungary
Tyra 300
3 G Oct 12, 2026
United States
tyra-300
1 G Oct 12, 2026
United States
dabogratinib
10 MG Oct 12, 2026 
Canada
TYRA-300
500 G Oct 12, 2026
United States
dabogratinib Tyra 300-2800223-30-5
5 G Oct 12, 2026 Post an enquiry for this product
